Recent Considerations in the Application of RAPTA‐C for Cancer Treatment and Perspectives for Its Combination with Immunotherapies
The organometallic ruthenium(II) [Ru(arene)Cl2PTA] PTA ‐ 1,3,5‐triaza‐7‐phosphaadamantane compound, RAPTA‐C, represents an innovative anti‐cancer therapeutic and a better‐tolerated alternative to platinum (Pt)‐based chemotherapeutic drugs in the treatment of cancer. RAPTA‐C exhibits anti‐metastatic, anti‐angiogenic, and anti‐tumoral activities through protein and histone–deoxyribonucleic acid alterations. In comparison to other ruthenium‐based drugs, which have been recently evaluated in clinical trials, RAPTA‐C is strikingly competitive, especially when administered in combination with other targeted drugs. In this review, the uniqueness of RAPTA‐C as an anti‐cancer chemotherapeutic compared to metal‐based drugs under clinical evaluation and those approved by the Food and Drug Administration is emphasized; specifically, comparing the application of RAPTA‐C to platinum‐based drugs, for example, cisplatin and oxaliplatin, as well as to prominent ruthenium‐based compounds, such as NAMI‐A imidazolium‐trans‐tetrachloro(dimethylsulfoxide) imidazoleruthenium(III) and trans‐[tetrachlorobis (1Hindazole) ruthenate(III)] (KP1019)/(N)KP1339 (N)KP1339 ‐ sodium. Additionally, the possible correlation between RAPTA‐C and immune response modulation, as well as potential applications of RAPTA‐C in combination with immune therapeutic regimens, is highlighted.
Топ-30
Журналы
|
2
4
6
8
10
|
|
|
Inorganic Chemistry
10 публикаций, 11.49%
|
|
|
Coordination Chemistry Reviews
8 публикаций, 9.2%
|
|
|
Journal of Medicinal Chemistry
6 публикаций, 6.9%
|
|
|
Dalton Transactions
5 публикаций, 5.75%
|
|
|
Applied Organometallic Chemistry
4 публикации, 4.6%
|
|
|
Pharmaceuticals
3 публикации, 3.45%
|
|
|
Molecules
3 публикации, 3.45%
|
|
|
Inorganica Chimica Acta
3 публикации, 3.45%
|
|
|
Chemistry - A European Journal
3 публикации, 3.45%
|
|
|
ChemMedChem
3 публикации, 3.45%
|
|
|
Pharmaceutics
2 публикации, 2.3%
|
|
|
European Journal of Medicinal Chemistry
2 публикации, 2.3%
|
|
|
Polyhedron
2 публикации, 2.3%
|
|
|
Journal of Materials Chemistry B
2 публикации, 2.3%
|
|
|
New Journal of Chemistry
2 публикации, 2.3%
|
|
|
Journal of Inorganic Biochemistry
2 публикации, 2.3%
|
|
|
Angewandte Chemie - International Edition
1 публикация, 1.15%
|
|
|
Journal of Physical Chemistry C
1 публикация, 1.15%
|
|
|
Molecular Pharmaceutics
1 публикация, 1.15%
|
|
|
Cancers
1 публикация, 1.15%
|
|
|
Journal of Biological Inorganic Chemistry
1 публикация, 1.15%
|
|
|
Biomaterials Advances
1 публикация, 1.15%
|
|
|
Current Opinion in Chemical Biology
1 публикация, 1.15%
|
|
|
Chemico-Biological Interactions
1 публикация, 1.15%
|
|
|
ChemBioChem
1 публикация, 1.15%
|
|
|
Chemical Record
1 публикация, 1.15%
|
|
|
Angewandte Chemie
1 публикация, 1.15%
|
|
|
Photochemistry and Photobiology
1 публикация, 1.15%
|
|
|
Chemistry and Biodiversity
1 публикация, 1.15%
|
|
|
ACS Omega
1 публикация, 1.15%
|
|
|
2
4
6
8
10
|
Издатели
|
5
10
15
20
25
|
|
|
Elsevier
23 публикации, 26.44%
|
|
|
American Chemical Society (ACS)
21 публикация, 24.14%
|
|
|
Wiley
17 публикаций, 19.54%
|
|
|
Royal Society of Chemistry (RSC)
12 публикаций, 13.79%
|
|
|
MDPI
10 публикаций, 11.49%
|
|
|
Springer Nature
1 публикация, 1.15%
|
|
|
Taylor & Francis
1 публикация, 1.15%
|
|
|
Hindawi Limited
1 публикация, 1.15%
|
|
|
Scientific Publishers
1 публикация, 1.15%
|
|
|
5
10
15
20
25
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.